Author:
Chishti Nahid Anjum Hafizuddin,Pathan Inayat Bashir,Dehghan Mohamed Hassan G.,Bairagi Shripad M.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Rades T, et al. Dipeptides as co-formers in co-amorphous systems. Eur J Pharm Biopharm. 2019;134:68–76.
2. Yamazaki R, Kawai S, Matsuzaki T, Kaneda N, Hashimoto S, Yokokura T, et al. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. Eur J Pharmacol. 1997;329:181–7.
3. Lee J, Lee Y, Kim J, Yoon M, Choi YW. Formulation of microemulsion systems for transdermal delivery of aceclofenac. Arch Pharm Res. 2005;28(9):1097–102
4. Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti- inflammatory drugs after topical application. J Pharmacol Exp Ther. 1994;268:144–51.
5. Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers. Transfersomes Biochim Biophys Acta - Biomembr. 2001;1514:191–205.